1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow SCLC: new trials by email Literature Review of SCLC trials Research Report on SCLC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell Toripalimab plus Anlotinib, Toripalimab - SCLC, Maintenance Treatment | Phase 3 | Not yet recruiting | Taizhou Hospital | 136 | 2024-07-01 | 2024-06-04 |
anlotinib (1) · toripalimab (1)
Taizhou Hospital (1)